Language and cultural health beliefs can negatively affect patients’ access to health care and their attitudes and acceptance of advice when they interact with providers. This is most often an issue for recent immigrants but can persist far longer among groups that retain their cultural identity and

FDA’s approval of Elevydys was based on a surrogate endpoint. The primary clinical outcome did not achieve statistical significance.